Johanna Friedl-Naderer

Direttore/Membro del Consiglio presso Biogen Idec Ltd.

Patrimonio netto: 215 855 $ in data 31/05/2024

56 anni

Health Technology

Commercial Services

Relazioni attive

Nome	Sesso	Età	Società collegate	Collaborazione
Caroline Dorsa	F	64	BIOGEN INC.	14 anni
Trevor Anthony Mill	M	53	BIOGEN INC. Biogen Idec Ltd. Biogen Idec Ltd. BiotechnologyHealth Technology Biogen Idec Ltd. develops therapies for neurodegenerative, haematologic, and autoimmune disorders. The firm develops treatment for Alzheimer’s Disease, spinal muscular atrophy, lupus, and amyotrophic lateral sclerosis (ALS), amongst others. The company was founded on 2003 and is headquartered in Maidenhead, the United Kingdom.	10 anni
Stephen Sherwin	M	75	BIOGEN INC.	14 anni
Maria Freire	M	69	BIOGEN INC.	3 anni
Michael Hencke	M	-	BIOGEN INC.	12 anni
Jesus Mantas	M	55	BIOGEN INC.	5 anni
William Hawkins	M	70	BIOGEN INC.	5 anni
Sung Lee	M	53	VIR BIOTECHNOLOGY, INC.	1 anni
Nicole Murphy	F	-	BIOGEN INC.	9 anni
Eric Rowinsky	M	67	BIOGEN INC.	14 anni
Susan Alexander	F	67	BIOGEN INC.	21 anni
Priya Singhal	M	56	BIOGEN INC.	3 anni
Natacha Gassenbach	F	-	BIOGEN INC.	6 anni
Rachid Izzar	M	-	BIOGEN INC.	3 anni
Michael McDonnell	M	60	BIOGEN INC.	4 anni
Sasha Ellis	F	-	VIR BIOTECHNOLOGY, INC.	1 anni
Lorraine Deborah Barr	F	58	Biogen Idec Ltd. Biogen Idec Ltd. BiotechnologyHealth Technology Biogen Idec Ltd. develops therapies for neurodegenerative, haematologic, and autoimmune disorders. The firm develops treatment for Alzheimer’s Disease, spinal muscular atrophy, lupus, and amyotrophic lateral sclerosis (ALS), amongst others. The company was founded on 2003 and is headquartered in Maidenhead, the United Kingdom.	-
Ginger Gregory	M	56	BIOGEN INC.	7 anni
Anabella Villalobos	M	65	BIOGEN INC.	7 anni
Neil Raymond Sisak	M	53	Biogen Idec Ltd. Biogen Idec Ltd. BiotechnologyHealth Technology Biogen Idec Ltd. develops therapies for neurodegenerative, haematologic, and autoimmune disorders. The firm develops treatment for Alzheimer’s Disease, spinal muscular atrophy, lupus, and amyotrophic lateral sclerosis (ALS), amongst others. The company was founded on 2003 and is headquartered in Maidenhead, the United Kingdom.	-
Steven John Green	M	47	Biogen Idec Ltd. Biogen Idec Ltd. BiotechnologyHealth Technology Biogen Idec Ltd. develops therapies for neurodegenerative, haematologic, and autoimmune disorders. The firm develops treatment for Alzheimer’s Disease, spinal muscular atrophy, lupus, and amyotrophic lateral sclerosis (ALS), amongst others. The company was founded on 2003 and is headquartered in Maidenhead, the United Kingdom.	-
Jeff Calcagno	M	-	VIR BIOTECHNOLOGY, INC.	1 anni
Jake Elkins	M	-	BIOGEN INC.	7 anni
Robin Kramer	F	58	BIOGEN INC.	6 anni
Michael Dambach	M	57	BIOGEN INC.	17 anni

Mostra altro

Grafico relazionale

Relazione in diverse aziende

Relazioni precedenti

Nome	Sesso	Età	Società collegate	Collaborazione
Howard Horn	M	47	BIOGEN INC. VIR BIOTECHNOLOGY, INC.	10 anni
Stelios Papadopoulos	M	75	BIOGEN INC.	15 anni
William Young	M	79	BIOGEN INC.	11 anni
Michel Vounatsos	M	62	BIOGEN INC.	6 anni
William Rastetter	M	75	BIOGEN INC.	19 anni
James Mullen	M	65	BIOGEN INC.	21 anni
Robert A. Hamm	M	72	BIOGEN INC.	7 anni
Brian Posner	M	62	BIOGEN INC.	14 anni
Alexander Denner	M	54	BIOGEN INC.	14 anni
Sylvie Grégoire	M	62	BIOGEN INC.	8 anni
Gregory Covino	M	59	BIOGEN INC.	6 anni
Gilmore O’Neill	M	59	BIOGEN INC.	15 anni
Paul Clancy	M	62	BIOGEN INC.	16 anni
Eric S. Hoffman	M	54	BIOGEN INC.	5 anni
Chirfi Guindo	M	58	BIOGEN INC.	5 anni
Dipchand Nishar	M	54	VIR BIOTECHNOLOGY, INC.	5 anni
Mahalakshmi Radhakrishnan	M	-	BIOGEN INC.	8 anni
Steven Rice	M	64	VIR BIOTECHNOLOGY, INC.	4 anni
Lynne Sullivan	F	58	BIOGEN INC.	10 anni
Douglas Kerr	M	57	BIOGEN INC.	2 anni
Samantha Truex	F	-	BIOGEN INC.	8 anni
Richard Mulligan	M	69	BIOGEN INC.	14 anni
George Scangos	M	76	BIOGEN INC.	7 anni
Phillip Sharp	M	79	BIOGEN INC.	31 anni
William Jones	M	68	BIOGEN INC.	2 anni
Nancy L. Leaming	F	76	BIOGEN INC.	14 anni
Jeffrey Capello	M	69	BIOGEN INC.	3 anni
Craig Eric Schneier	M	76	BIOGEN INC.	8 anni
Michael Gilman	M	69	BIOGEN INC.	8 anni
Joseph Mara	M	49	BIOGEN INC.	-
Carlos Costa	M	51	BIOGEN INC.	7 anni
Gina Consylman	F	52	BIOGEN INC.	3 anni
Robert W. Pangia	M	72	BIOGEN INC.	24 anni
Lynn Schenk	F	79	BIOGEN INC.	25 anni
Stacy Lindborg	M	53	BIOGEN INC.	8 anni
Mark Baldry	M	60	BIOGEN INC.	-
Bolyn Hubby	M	-	VIR BIOTECHNOLOGY, INC.	3 anni
Philip Ma	M	59	BIOGEN INC.	2 anni
Johny Humaloja	M	58	BIOGEN INC.	5 anni
Herbert Virgin	M	68	VIR BIOTECHNOLOGY, INC.	4 anni
Samantha Vieira	F	-	BIOGEN INC.	2 anni
Marc Schegerin	M	48	BIOGEN INC.	4 anni
David W Miller	M	-	BIOGEN INC.	7 anni
Andrea DiMella	F	-	BIOGEN INC.	3 anni
Orly Mishan	F	-	BIOGEN INC.	2 anni
James Kelly	M	58	BIOGEN INC.	5 anni
F. Edmondson	M	58	BIOGEN INC.	6 anni
Adrian Gottschalk	M	49	BIOGEN INC.	2 anni
Michael E. Markels	M	-	BIOGEN INC.	1 anni
Thomas F. Keller	M	92	BIOGEN INC.	-
John Cox	M	61	BIOGEN INC.	14 anni
Hans-Peter Hasler	M	68	BIOGEN INC.	8 anni
Robert Perez	M	59	BIOGEN INC.	8 anni
Anne Cook	F	62	BIOGEN INC.	13 anni
Douglas A. Abel	M	62	BIOGEN INC.	4 anni
Arturo Molina	M	65	BIOGEN INC.	4 anni
Raymond Pawlicki	M	63	BIOGEN INC.	6 anni
Steven Holtzman	M	70	BIOGEN INC.	5 anni
William R. Rohn	M	80	BIOGEN INC.	2 anni
Bruce R. Ross	M	83	BIOGEN INC.	13 anni
Alan Belzer	M	91	BIOGEN INC.	10 anni
Mary L. Good	M	93	BIOGEN INC.	10 anni
Rowe Heather Armstrong	F	-	VIR BIOTECHNOLOGY, INC.	-
Alfred Sandrock	M	67	BIOGEN INC.	23 anni
Robert L. de Jager	M	82	BIOGEN INC.	-
Elizabeth Woo	F	57	BIOGEN INC.	12 anni
Kenneth DiPietro	M	65	BIOGEN INC.	5 anni
Christopher Anzalone	M	54	VIR BIOTECHNOLOGY, INC.	-
Patrick Volkert Vink	M	60	BIOGEN INC.	2 anni
Dinah Sah	M	63	BIOGEN INC.	6 anni
Pratik Multani	M	57	BIOGEN INC.	5 anni
Eric W. Kimble	M	58	BIOGEN INC.	5 anni
Robert Gagnon	M	49	BIOGEN INC.	7 anni
Caren Deardorf	F	59	BIOGEN INC.	2 anni
Minnie Kuo	F	-	VIR BIOTECHNOLOGY, INC.	6 anni

Statistiche

Paese	Relazioni	% del totale
Stati Uniti	97	97.00%
Regno Unito	4	4.00%

Età delle relazioni

Attive

Scorse

Uomo

Donna

Amministratori

Dirigenti

Provenienza delle relazioni